A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body

NCT02688088 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm Metastasis

Interventions

DRUG: Drug Cocktail
DRUG: Abemaciclib

Sponsor

Eli Lilly and Company